Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MAX-R - Health Canada Drug Approval Details

Approvals/Health Canada/MAX-R

Authorized

STANDARD

MAX-R

LIBERCHEM INC.🇨🇦 Health Canada

Approval Date: Feb 6, 2026
Approval ID: 1348d2463d6843f5
Company: LIBERCHEM INC.
Type: Standard

Approval Details

Approval Id: 1348d2463d6843f5
Drug Approval Canada Name: MAX-R
Product Name: MAX-R
Status: Marketed
Status Date: 2016-10-11
Original Market Date: 2016-10-11
Din: 02455773
Drug Class: Veterinary
Dosage Form: Solution
Route Of Administration: Topical
Schedule: NON-PRESCRIPTION DRUGS
Atc Original: Not Applicable
Aig Number: 0216755003
Company Name: LIBERCHEM INC.
Company Address: 572 Avenue Orly Dorval Quebec Canada H9P 1E9

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 6, 2026

Approval ID

1348d2463d6843f5

Type

Standard

Back to Health Canada Approvals